The University of Glasgow will lead an innovative Pan-European research training program targeting incurable prostate cancer.
The four-year Translational Research Network for Prostate Cancer (TransPot) aims to provide a multidisciplinary training program, integrating cancer biology and systems medicine to enable young researchers to become future leaders in cancer research.
A partnership between academic and industrial institutions in the UK, Finland,...
A ground-breaking new pancreatic cancer trial, which aims to match patients with more targeted and effective treatment for their tumours, is to begin in Scotland.
Run by Precision-Panc, a research programme and clinical trials project led by the University of Glasgow, the trial will bring a precision medicine approach to pancreatic cancer treatment for the first time in the UK.
Pancreatic cancer is the 5th most common cause of cancer death in the UK wi...
The antibiotic tigecycline, when used in combination with current treatment, may hold the key to eradicating chronic myeloid leukaemia (CML) cells, according to new research.
The University of Glasgow led study, published today in Nature Medicine, demonstrates the effectiveness of combining tigecycline with the drug imatinib – a tyrosine kinase inhibitor (TKI) and standard first-line treatment of patients with CML.